 ThirdAge [1] |
FDA Okays Byetta Plus Insulin Glargine [2]
MedPage Today WASHINGTON — The FDA has approved a new indication for the type 2 diabetes drug exenatide (Byetta) as an add-on therapy with insulin glargine, diet, and exercise for adult patients. … Byetta Receives Expanded Approval from FDA, as Reported by DiabeticLive.com [3]San Francisco Chronicle (press release) FDA approves Byetta as insulin glargine add-on [4]Clinical Advisor Byetta (exenatide) Approved In Combination With Glargine For Type 2 Diabetes [5]Medical News Today ThirdAge [1] –Endocrine Today [6] –Wall Street Journal [7] all 58 news articles » [8] |
More details can be found at www.diabeteshowto.com [9]